Volume 1, Issue 2 (Avicenna Journal of Pharmaceutical Research, Dec 2021)                   Avicenna J Pharma Res 2021, 1(2): 72-75 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Makhdoomi S, Oftade A, Khodabandehlou S, Ranjbar A. Pulmonary Protective Effects of Propofol on Cisplatin-Induced Oxidative Damage in Male Rats. Avicenna J Pharma Res 2021; 1 (2) :72-75
URL: http://ajpr1.umsha.ac.ir/article-1-56-en.html
1- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran & Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan
2- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran & Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract:   (2 Views)

Background: The present study was performed to investigate the protective effects of propofol against cisplatin-induced pulmonary toxicity in rats.

Methods: A total of 20 male Wistar rats weighing 180-250 g were divided into four groups of control, the cisplatin-intoxicated group intraperitoneally (IP) injected with cisplatin (7 mg/kg/d for a week), the propofol group (10 mg/kg/d, IP), and the protected group receiving propofol (10 mg/kg/d, IP) poisoned by cisplatin. Then, the biomarkers of total antioxidant capacity (TAC), catalase (CAT) activity, and lipid peroxidation (LPO) were measured in homogeneous lung tissues.

Results: The data revealed the evidence of oxidative stress in the lung tissue of cisplatin-intoxicated rats as indicated by an increase in the level of LPO compared with propofol and protected groups (P<0.05). Moreover, TAC decreased in the cisplatin group while it increased in the propofol group compared to cisplatin and protected groups (P<0.05). No significant difference was observed between the groups regarding CAT (P>0.05). Protection with propofol ameliorated the oxidative stress induced by cisplatin in the lung tissue because of the reduction of LPO.

Conclusion: According to these results, it seems that propofol provides a remarkable protection against cisplatin-induced oxidative pulmonary damage mediated by its antioxidant properties.

Full-Text [PDF 345 kb]   (2 Downloads)    
Type of Study: case report | Subject: General
Received: 2026/09/28 | Accepted: 2021/02/28 | Published: 2026/09/29

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Avicenna Journal of Pharmaceutical Research

Designed & Developed by : Yektaweb